These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17272541)

  • 1. 500m dollars investment in poor countries' health systems will boost vaccination.
    Zarocostas J
    BMJ; 2007 Feb; 334(7587):225. PubMed ID: 17272541
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
    Jeuland M; Whittington D
    Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

  • 4. Can investments in health systems strategies lead to changes in immunization coverage?
    Brenzel L
    Expert Rev Vaccines; 2014 Apr; 13(4):561-72. PubMed ID: 24588785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insufficient vaccination is a threat against world health].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 2003 Mar; 123(6):831. PubMed ID: 12693127
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
    Valenzuela MT; Jacobs RJ; Arteaga O; Navarrete MS; Meyerhoff AS; Innis BL
    Vaccine; 2005 Jul; 23(32):4110-9. PubMed ID: 15964479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing financial barriers to vaccinating children and adolescents in the USA.
    Bednarczyk RA; Birkhead GS
    Curr Opin Pediatr; 2011 Feb; 23(1):105-9. PubMed ID: 21150447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making the leap into the next generation: A commentary on how Gavi, the Vaccine Alliance is supporting countries' supply chain transformations in 2016-2020.
    Brooks A; Habimana D; Huckerby G
    Vaccine; 2017 Apr; 35(17):2110-2114. PubMed ID: 28364917
    [No Abstract]   [Full Text] [Related]  

  • 10. Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?
    Lydon P; Gandhi G; Vandelaer J; Okwo-Bele JM
    Bull World Health Organ; 2014 May; 92(5):382-4. PubMed ID: 24839329
    [No Abstract]   [Full Text] [Related]  

  • 11. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating sustainable financing and support for immunization programs in fifteen developing countries.
    McQuestion M; Gnawali D; Kamara C; Kizza D; Mambu-Ma-Disu H; Mbwangue J; de Quadros C
    Health Aff (Millwood); 2011 Jun; 30(6):1134-40. PubMed ID: 21653967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccines: new needs, new possibilities.
    Aziz MA; Midha S; Waheed SM; Bhatnagar R
    Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regional Plan for Investments in Environment and Health for Latin America and the Caribbean].
    Bol Oficina Sanit Panam; 1996 Jun; 120(6):538-41. PubMed ID: 8754666
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted.
    Franco EL
    BMJ; 2007 Aug; 335(7616):378-9. PubMed ID: 17717367
    [No Abstract]   [Full Text] [Related]  

  • 17. Community-level incentives to increase the use of vaccination services in developing countries: an idea whose time has come?
    Behl AS; Vijayaraghavan M; Nordin JD; Maciosek MV; Strebel PM
    Vaccine; 2010 Aug; 28(38):6123-4. PubMed ID: 20637772
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy analysis: an essential research tool for the introduction of vaccines in developing countries.
    Mahoney R
    J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global vaccination meets global terror.
    CMAJ; 2002 Oct; 167(8):837, 839. PubMed ID: 12406926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.